%0 Journal Article
%A Hidalgo-Tenorio, Carmen
%A Cortés, Luis López
%A Gutiérrez, Alicia
%A Santos, Jesús
%A Omar, Mohamed
%A Gálvez, Carmen
%A Sequera, Sergio
%A Jesús, Samantha Eisabeth De
%A Téllez, Franciso
%A Fernández, Elisa
%A García, Coral
%A Pasquau, Juan
%T DOLAMA study: Effectiveness, safety and pharmacoeconomic analysis of dual therapy with dolutegravir and lamivudine in virologically suppressed HIV-1 patients.
%D 2019
%U http://hdl.handle.net/10668/14378
%X Dolutegravir (DTG) has shown effectiveness in combination with rilpivirine in with experience of antiretroviral therapy (ART) and with 3TC in naïve patients (GEMINI trial). The main objectives of this real-life study were to analyze the effectiveness and safety of 3TC plus DTG in virologically suppressed HIV-1 patients and to conduct a pharmacoeconomic analysis.We conducted an observational, retrospective and multicenter study of HIV+ patients pretreated for at least 6 months with ART that was then simplified to 3TC + DTG for any reason. We gathered data on viral loads (VLs) during exposure to the DT, calculating the rate with VL
%~